Coccidioidomicose

Referências

Principais artigos

Thompson GR 3rd, Le T, Chindamporn A, et al. Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology. Lancet Infect Dis. 2021 Dec;21(12):e364-74. Resumo

Galgiani JN, Ampel NM, Blair JE, et al. 2016 Infectious Diseases Society of America (IDSA) clinical practice guideline for the treatment of coccidioidomycosis. Clin Infect Dis. 2016 Sep 15;63(6):e112-46. Resumo

Centers for Disease Control and Prevention; National Institutes of Health; HIV Medicine Association of the Infectious Diseases Society of America. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV. November 2021 [internet publication].Texto completo

Hage CA, Carmona EM, Epelbaum O, et al. Microbiological laboratory testing in the diagnosis of fungal infections in pulmonary and critical care practice. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2019 Sep 1;200(5):535-50.Texto completo  Resumo

Limper AH, Knox KS, Sarosi GA, et al; American Thoracic Society Fungal Working Group. An official American Thoracic Society statement: treatment of fungal infections in adult pulmonary and critical care patients. Am J Respir Crit Care Med. 2011 Jan 1;183(1):96-128.Texto completo  Resumo

Artigos de referência

1. Pappagianis D, Zimmer BL. Serology of coccidioidomycosis. Clin Microbiol Rev. 1990 Jul;3(3):247-68. Resumo

2. Galgiani J. Coccidioides immitis. In: Mandel GL, Bennett JE, Dolin RE, eds. Principles and practice of infectious diseases. 6th ed. New York: Churchill Livingstone; 2005:2746-57.

3. Sunenshine RH, Anderson S, Erhart L, et al. Public health surveillance for coccidioidomycosis in Arizona. Ann NY Acad Sci. 2007 Sep;1111:96-102. Resumo

4. Thompson GR 3rd, Le T, Chindamporn A, et al. Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology. Lancet Infect Dis. 2021 Dec;21(12):e364-74. Resumo

5. Galgiani JN, Ampel NM, Blair JE, et al. 2016 Infectious Diseases Society of America (IDSA) clinical practice guideline for the treatment of coccidioidomycosis. Clin Infect Dis. 2016 Sep 15;63(6):e112-46. Resumo

6. Centers for Disease Control and Prevention. Valley fever (coccidioidomycosis) statistics. Apr 2022 [internet publication].Texto completo

7. Ruddy BE, Mayer AP, Ko MG, et al. Coccidioidomycosis in African Americans. Mayo Clin Proc. 2011 Jan;86(1):63-9. Resumo

8. Crum NF, Ballon-Landa G. Coccidioidomycosis in pregnancy: case report and review of the literature. Am J Med. 2006 Nov;119(11):993.e11-7. Resumo

9. Spinello IM, Johnson RH, Baqi S. Coccidioidomycosis in pregnancy: a review. Ann NY Acad Sci. 2007 Sep;1111:358-64. Resumo

10. Fisher MC, Koenig GL, White TJ, et al. Molecular and phenotypic description of Coccidioides posadasii sp. nov., previously recognized as the non-California population of Coccidioides immitis. Mycologia. 2002 Jan-Feb;94(1):73-84. Resumo

11. Hector RF, Laniado-Laborin R. Coccidioidomycosis: a fungal disease of the Americas. PLoS Med. 2005 Jan;2(1):e2.Texto completo  Resumo

12. Kirkland T, Fierer J. Coccidioidomycosis: a reemerging infectious disease. Emerg Infect Dis. 1996 Jul-Sep;2(3):192-9. Resumo

13. Anstead GM, Graybill JR. Coccidioidomycosis. Infect Dis Clin North Am. 2006 Sep;20(3):621-43. Resumo

14. Ampel MA. Coccidiodomycosis in persons infected with HIV type 1. Clin Infect Dis. 2005 Oct 15;41(8):1174-8.Texto completo  Resumo

15. Blair JE, Logan JL. Coccidioidomycosis in solid organ transplantation. Clin Infect Dis. 2001 Nov 1;33(9):1536-44. Resumo

16. Glenn TJ, Blair JE, Adams RH. Coccidioidomycosis in hematopoietic stem cell transplant recipients. Med Mycol. 2005 Dec;43(8):705-10. Resumo

17. Santelli AC, Blair JE, Roust LR. Coccidioidomycosis in patients with diabetes mellitus. Am J Med. 2006 Nov;119(11):964-9. Resumo

18. Centers for Disease Control and Prevention; National Institutes of Health; HIV Medicine Association of the Infectious Diseases Society of America. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV. November 2021 [internet publication].Texto completo

19. Crum NF, Lederman ER, Stafford CM, et al. Coccidioidomycosis: a descriptive survey of a reemerging disease. Clinical characteristics and current controversies. Medicine (Baltimore). 2004 May;83(3):149-75. Resumo

20. Valdivia L, Nix D, Wright M, et al. Coccidioidomycosis as a common cause of community-acquired pneumonia. Emerg Infect Dis. 2006 Jun;12(6):958-62.Texto completo  Resumo

21. Hage CA, Carmona EM, Epelbaum O, et al. Microbiological laboratory testing in the diagnosis of fungal infections in pulmonary and critical care practice. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2019 Sep 1;200(5):535-50.Texto completo  Resumo

22. Blair JE, Coakley B, Santelli AC, et al. Serologic testing for symptomatic coccidioidomycosis in immunocompetent and immunosuppressed hosts. Mycopathologia. 2006 Nov;162(5):317-24. Resumo

23. Saubolle MA. Laboratory aspects in the diagnosis of coccidioidomycosis. Ann N Y Acad Sci. 2007 Sep;1111:301-14. Resumo

24. Chiller TM, Galgiani JN, Stevens DA. Coccidioidomycosis. Infect Dis Clin North Am. 2003;17:41-57. Resumo

25. Saubolle MA, McKellar PP, Sussland D. Epidemiologic, clinical and diagnostic aspects of coccidioidomycosis. J Clin Microbiol. 2007 Jan;45(1):26-30.Texto completo  Resumo

26. Galgiani JN, Ampel NM, Blair JE, et al. Coccidioidomycosis. Clin Infect Dis. 2005 Nov 1;41(9):1217-23.Texto completo  Resumo

27. Batra P, Batra RS. Thoracic coccidioidomycosis. Semin Roentgenol. 1996 Jan;31(1):28-44. Resumo

28. Zeppa MA, Laorr A, Greenspan A, et al. Skeletal coccidioidomycosis: imaging findings in 19 patients. Skeletal Radiol. 1996 May;25(4):337-43. Resumo

29. Wheat LJ, Kauffman CA. Histoplasmosis. Infect Dis Clin North Am. 2003 Mar;17(1):1-19, Resumo

30. Chapman SW. Blastomyces dermatiditis. In: Mandel GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. 6th ed. New York: Churchill Livingstone; 2005:448-59.

31. Limper AH, Knox KS, Sarosi GA, et al; American Thoracic Society Fungal Working Group. An official American Thoracic Society statement: treatment of fungal infections in adult pulmonary and critical care patients. Am J Respir Crit Care Med. 2011 Jan 1;183(1):96-128.Texto completo  Resumo

32. Prabhu RM, Bonnell M, Currier BL, et al. Successful treatment of disseminated nonmeningeal coccidioidomycosis with voriconazole. Clin Infect Dis. 2004 Oct 1;39(7):e74-7. Resumo

33. Caraway NP, Fanning CV, Stewart JM, et al. Coccidioidomycosis osteomyelitis masquerading as a bone tumor: a report of 2 cases. Acta Cytol. 2003 Sep-Oct;47(5):777-82. Resumo

34. Stevens DA, Rendon A, Gaona Flores V, et al. Posaconazole therapy for chronic refractory coccidioidomycosis. Chest. 2007 Sep;132(3):952-8. Resumo

35. Catanzaro A, Cloud GA, Stevens DA, et al. Safety, tolerance, and efficacy of posaconazole therapy in patients with nonmeningeal disseminated or chronic pulmonary coccidioidomycosis. Clin Infect Dis. 2007 Sep 1;45(5):562-8. Resumo

36. Rachwalski EJ, Wieczorkiewicz JT, Scheetz MH. Posaconazole: an oral triazole with an extended spectrum of activity. Ann Pharmacother. 2008 Oct;42(10):1429-38. Resumo

37. Kim MM, Vikram HR, Kusne S, et al. Treatment of refractory coccidioidomycosis with voriconazole or posaconazole. Clin Infect Dis. 2011 Dec;53(11):1060-6. Resumo

38. Blair JE. State-of-the-art treatment of coccidioidomycosis: skin and soft-tissue infections. Ann N Y Acad Sci. 2007 Sep;1111:411-21. Resumo

39. Blair JE. State-of-the-art treatment of coccidioidomycosis: skeletal infections. Ann N Y Acad Sci. 2007 Sep;1111:422-33. Resumo

40. Galgiani JN, Catanzaro A, Cloud GA, et al. Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis. A randomized, double-blind trial. Mycoses Study Group. Ann Intern Med. 2000 Nov 7;133(9):676-86. Resumo

41. Goldstein EJ, Johnson RH, Einstein HE. Coccidioidal meningitis. Clin Infect Dis. 2006 Jan 1;42(1):103-7.Texto completo  Resumo

42. Wiederhold NP, Shubitz LF, Najvar LK, et al. The novel fungal Cyp51 inhibitor VT-1598 is efficacious in experimental models of central nervous system coccidioidomycosis caused by coccidioides posadasii and coccidioides immitis. Antimicrob Agents Chemother. 2018 Apr;62(4):.Texto completo  Resumo

O uso deste conteúdo está sujeito ao nosso aviso legal